Akt Pathway Discovery
From Target Selection to Lead Profiling

Optimized solutions ensure higher quality hits resulting in fewer false leads
The Akt/PKB pathway is a popular target since it sits at the crossroads of both oncogenic and tumor suppressor signaling pathways. Enzo provides novel tools to help support cancer discovery from target selection, hit-to-lead discovery, and lead profiling.
SCREEN-WELL® Kinase Inhibitor Library
Benchmark against 80 known kinase inhibitors with well-defined activity. Our focused compounds are well-characterized and annotated to their corresponding target kinase.

Wortmannin, a PI 3-Kinase inhibitor
PKA, PKB, PKC Kinase Activity Assays
Our non-radioactive protein kinase assays provides rapid and sensitive detection of PKA, PKB, or PKC.

Analysis of purified PKB activity
CELLESTIAL® Assays
Enzo offers a broad range of next-generation, high specificity, and low background fluorescent probes for live cell analysis.

Multiplex assay that distinguishes between apoptosis and necrosis